Patent Assignment
Reel/Frame 047031/0830
Assignment of Assignor's Interest
Recorded: 2018-10-02
Pages: 3
Assignor
SPEAKE, JASON D.
Executed: 2018-08-21
Assignee
AVISTA PHARMA SOLUTIONS, INC.
3501 TRICENTER BLVD., DURHAM, NORTH CAROLINA, 27713
Covered Property
(1)
A COMPOUND 1-[2-[4-(2-ETHYL-6,8-DIMETHYLIMIDAZO[1,2-a]PYRAZIN-3-YL)PHENYL]ETHYL]-3-(p-TOLYLSULFONYL)UREA AS A PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST
Patent:
10,239,885 →
Application:
16/100,315 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Second Lien Patent Security Agreement
Dec 4, 2019
From: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051196/0080 →
First Lien Patent Security Agreement
Dec 4, 2019
From: AVISTA PHARMA SOLUTIONS, INC.; CAMBREX CHARLES CITY, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 051283/0877 →
Release of Second Lien Security Interest in Patents
Dec 7, 2020
From: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
To: AVISTA PHARMA SOLUTIONS, INC.
Reel/Frame 054630/0307 →
Security Interest
Mar 6, 2025
From: AVISTA PHARMA SOLUTIONS, INC.
To: ARES AGENT SERVICES, L.P., AS COLLATERAL AGENT
Reel/Frame 070421/0835 →
Release of First Lien Security Interest in Patents
Mar 6, 2025
From: ROYAL BANK OF CANADA
To: CAMBREX CHARLES CITY, INC.; AVISTA PHARMA SOLUTIONS, INC.; SNAPDRAGON CHEMISTRY, INC.
Reel/Frame 070438/0333 →
Assignment and Assumption of Intellectual Property Security Agreement
Apr 11, 2025
From: ARES AGENT SERVICES, L.P., AS FORMER AGENT
To: BLUE OWL CAPITAL CORPORATION, AS NEW AGENT
Reel/Frame 070821/0302 →